National Health Amendment (Passive Immunological Products) Bill 2026
Amends the National Health Act 1953 to amend the definition of ‘vaccine’ to enable new and merging technologies to be listed on the National Immunisation Program.
Summary from the official bill homepage.
Became law
| Act | National Health Amendment (Passive Immunological Products) Act 2026 |
|---|---|
| Number | No. 34, 2026 |
| Assent | 8 Apr 2026 |
| Status | In force |
Sourced from the Federal Register of Legislation at 21 Oct 2026. For the latest information on Australian Government law please go to https://www.legislation.gov.au.
Progress
| Date | Step |
|---|---|
| House | |
| 5 Feb 2026 | Introduced and read a first time |
| 5 Feb 2026 | Second reading moved |
| 10 Feb 2026 | Second reading debate |
| 10 Feb 2026 | Referred to Federation Chamber |
| 11 Feb 2026 | Second reading debate |
| 11 Feb 2026 | Second reading agreed to |
| 12 Feb 2026 | Reported from Federation Chamber |
| 12 Feb 2026 | Third reading agreed to |
| Senate | |
| 3 Mar 2026 | Introduced and read a first time |
| 3 Mar 2026 | Second reading moved |
| 1 Apr 2026 | Second reading agreed to |
| 1 Apr 2026 | Third reading agreed to |
| 1 Apr 2026 | Finally passed both Houses |
| 8 Apr 2026 | Assent |
Divisions on this bill
- 1 Apr 2026 National Health Amendment (Passive Immunological Products) Bill 2026 - Limitation of Debate - Vaccines to be tested against an inert saline placebo Negatived Senate 5–43
- 1 Apr 2026 National Health Amendment (Passive Immunological Products) Bill 2026 - Limitation of Debate - Pass the bill Carried Senate 39–5
Official record: bill homepage at aph.gov.au, full text and documents on ParlInfo.